Mothers’ perceptions and attitudes about HPV vaccination initiation among 9- and 10-year-olds

References

• Lehtinen M, Lagheden C, Luostarinen T, Eriksson T, Apter D, Harjula K, Kuortti M, Natunen K, Palmroth J, Petäjä T, et al. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials. BMJ Open. 2017;7(8):e015867. doi:10.1136/bmjopen-2017-015867.
   PubMed Web of Science ®Google Scholar
• Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. JNCI J Nat Cancer Inst. 2015 Jun;107(6):djv086. doi:10.1093/jnci/djv086.
   PubMedGoogle Scholar
• Huh WK, Joura EA, Giuliano AR, Iversen OE, de Andrade RP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, et al. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial. Lancet. 2017 Nov 11;390(10108):2143–9. doi:10.1016/s0140-6736(17)31821-4.
   PubMed Web of Science ®Google Scholar
• Palmer T, Wallace L, Pollock KG, Cuschieri K, Robertson C, Kavanagh K, Cruickshank M. Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study. BMJ (Clinical Research Ed). 2019;365:l1161. doi:10.1136/bmj.l1161.
   PubMedGoogle Scholar
• Skinner SR, Apter D, De Carvalho N, Harper DM, Konno R, Paavonen J, Romanowski B, Roteli-Martins C, Burlet N, Mihalyi A, et al. Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases. Expert Rev Vaccines. 2016 Mar 3;15(3):367–87. doi:10.1586/14760584.2016.1124763.
   PubMed Web of Science ®Google Scholar
• Mesher D, Panwar K, Thomas SL, Beddows S, Soldan K. Continuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study. BMJ Open. 2016;6(2):e009915. doi:10.1136/bmjopen-2015-009915.
   PubMed Web of Science ®Google Scholar
• Petrosky E, Bocchini JA Jr., Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015 Mar 27;64(11):300–4.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Calo WA, Moss JL, Shah PD, Marciniak MW, Brewer NT. Provider communication and HPV vaccination: the impact of recommendation quality. Vaccine. 2016 Feb 24;34(9):1187–92. doi:10.1016/j.vaccine.2016.01.023.
   PubMed Web of Science ®Google Scholar
• Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C. Announcements versus conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics. 2017 Jan;139(1). doi:10.1542/peds.2016-1764
   PubMed Web of Science ®Google Scholar
• Center for Disease Control and Prevention. Immunization education & training: you call the shots.
   Google Scholar
• New Jersey Department of Health. Data brief: adolescent vaccination. 2022.
   Google Scholar
• Chido-Amajuoyi OG, Talluri R, Wonodi C, Shete S. Trends in HPV vaccination initiation and completion within ages 9–12 years: 2008–2018. Pediatrics. 2021;147(6). doi:10.1542/peds.2020-012765.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. TeenVaxView: vaccination coverage among adolescents (13–17 years); [accessed 2023 Sep 19]. https://www.cdc.gov/vaccines/imz-managers/coverage/teenvaxview/data-reports/index.html.
   Google Scholar
• Blue Cross Blue Shield Association, Blue Health Intelligence. Adolescent vaccination rates in America. The Health of America Report; 2018. https://www.bcbs.com/the-health-of-america/reports/adolescent-vaccination-rates-in-america.
   Google Scholar
• Prabhu VS, Bansal N, Liu Z, Finalle R, Sénécal M, Kothari S, Trowers K, Myers E. HPV vaccination uptake and administration from 2006 to 2016 in a commercially insured population of the United States. BMC Public Health. 2021 Sep 6;21(1):1629. doi:10.1186/s12889-021-11664-1.
   PubMed Web of Science ®Google Scholar
• Guo Y, Bowling J. Human papillomavirus (HPV) vaccination initiation and completion among adult males in the United States. J Am Board Fam Med. 2020 Jul–Aug;33(4):592–9. doi:10.3122/jabfm.2020.04.190464.
   PubMed Web of Science ®Google Scholar
• Wiener RC, Findley PA, Shen C, Dwibedi N, Sambamoorthi U. Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015. Vaccine. 2020 Jul 14;38(33):5119–22. doi:10.1016/j.vaccine.2020.05.056.
   PubMed Web of Science ®Google Scholar
• Coyne-Beasley T, Ortiz RR. Recommending HPV vaccination at age 9 to reduce health disparities: communication challenges and opportunities. Hum Vaccin Immunother. 2023;19(1):2178219. doi:10.1080/21645515.2023.2178219.
   PubMed Web of Science ®Google Scholar
• American Cancer Society. ACS elimination statement on HPV cancers; 2023. https://www.cancer.org/healthy/hpv-vaccine.html.
   Google Scholar
• O’Leary ST. Why the American Academy of Pediatrics recommends initiating HPV vaccine at age 9. Hum Vaccin Immunother. 2022 Nov 30;18(6):2146434. doi:10.1080/21645515.2022.2146434.
   PubMed Web of Science ®Google Scholar
• Kajtezovic S, Morgan JR, Fiascone S, Brandt HM, Perkins RB. Optimizing timing of adolescent vaccines: impact of initiating HPV vaccination before Tdap or meningococcal vaccination on timely completion of the HPV vaccine series. Hum Vaccin Immunother. 2023 Dec 31;19(1):2175541. doi:10.1080/21645515.2023.2175541.
   PubMed Web of Science ®Google Scholar
• Farias AJ, Savas LS, Fernandez ME, Coan SP, Shegog R, Healy CM, Lipizzi E, Vernon SW. Association of physicians perceived barriers with human papillomavirus vaccination initiation. Prev Med. 2017 Dec 1;105:219–25. doi:10.1016/j.ypmed.2017.07.016.
   PubMed Web of Science ®Google Scholar
• Apter D, Wheeler CM, Paavonen J, Castellsagué X, Garland SM, Skinner SR, Naud P, Salmerón J, Chow SN, Kitchener HC, et al. Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial. Clin Vaccine Immunol. 2015 Apr;22(4):361–73. doi:10.1128/cvi.00591-14.
   PubMedGoogle Scholar
• New Research Reinforces American Cancer Society And American Academy Of Pediatrics Recommendation To Start HPV Vaccines At Age Nine. 2023. https://pressroom.cancer.org/releases?item=1205.
   Google Scholar
• Saxena K, Kathe N, Sardana P, Yao L, Chen Y-T, Brewer NT. HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US. Hum Vaccin Immunother. 2023 Dec 31;19(1):2161253. doi:10.1080/21645515.2022.2161253.
   PubMed Web of Science ®Google Scholar
• Goodman E, Felsher M, Wang D, Yao L, Chen Y-T. Early initiation of HPV vaccination and series completion in early and mid-adolescence. Pediatrics. 2023;151(3). doi:10.1542/peds.2022-058794.
   Web of Science ®Google Scholar
• St Sauver JL, Rutten LJF, Ebbert JO, Jacobson DJ, McGree ME, Jacobson RM. Younger age at initiation of the human papillomavirus (HPV) vaccination series is associated with higher rates of on-time completion. Prev Med. 2016 Aug;89:327–33. doi:10.1016/j.ypmed.2016.02.039.
   PubMed Web of Science ®Google Scholar
• Minihan AK, Bandi P, Star J, Fisher-Borne M, Saslow D, Jemal A. The association of initiating HPV vaccination at ages 9–10 years and up-to-date status among adolescents ages 13–17 years, 2016-2020. Hum Vaccin Immunother. 2023 Dec 31;19(1):2175555. doi:10.1080/21645515.2023.2175555.
   PubMed Web of Science ®Google Scholar
• Goleman MJ, Dolce M, Morack J. Quality improvement initiative to improve human papillomavirus vaccine initiation at 9 years of age. Acad Pediatr. 2018;18(7):769–75. doi:10.1016/j.acap.2018.05.005.
   PubMed Web of Science ®Google Scholar
• Perkins RB, Legler A, Jansen E, Bernstein J, Pierre-Joseph N, Eun TJ, Biancarelli DL, Schuch TJ, Leschly K, Fenton ATHR, et al. Improving HPV vaccination rates: a stepped-wedge randomized trial. Pediatrics. 2020;146(1). doi:10.1542/peds.2019-2737.
   PubMed Web of Science ®Google Scholar
• Zorn S, Darville - Sanders G, Vu T, Carter A, Treend K, Raunio C, Vasavada A. Multi-level quality improvement strategies to optimize HPV vaccination starting at the 9-year well child visit: success stories from two private pediatric clinics. Hum Vaccin Immunother. 2023 Dec 31;19(1):2163807. doi:10.1080/21645515.2022.2163807.
   PubMed Web of Science ®Google Scholar
• Bednarczyk RA, Brandt HM. Descriptive epidemiology of age at HPV vaccination: analysis using the 2020 NIS-Teen. Hum Vaccin Immunother. 2023 Dec 31;19(1):2204784. doi:10.1080/21645515.2023.2204784.
   PubMed Web of Science ®Google Scholar
• Bureau USC. QuickFacts: jersey City, New Jersey; Newark city, New Jersey. U.S. Department of Commerce. https://www.census.gov/quickfacts/fact/table/jerseycitycitynewjersey,newarkcitynewjersey/PST045222.
   Google Scholar
• McCann A. Most & least ethnically diverse cities in the U.S. WalletHub; 2023. https://wallethub.com/edu/cities-with-the-most-and-least-ethno-racial-and-linguistic-diversity/10264#video.
   Google Scholar
• World Health Organization. Report of the SAGE working group on vaccine hesitancy; 2014 [accessed 2022 Sept 26]. https://cdn.who.int/media/docs/default-source/immunization/sage/2014/october/2-sage-appendicies-background-final.pdf?sfvrsn=2259f1bf_4.
   Google Scholar
• Brewer NT, Chapman GB, Rothman AJ, Leask J, Kempe A. Increasing vaccination: putting psychological science into action. Psychol Sci Public Interest. 2017 Dec;18(3):149–207. doi:10.1177/1529100618760521.
   PubMed Web of Science ®Google Scholar
• Kohler RE, Wagner RB, Careaga K, Vega J, Btoush R, Greene K, Kantor L. Parents’ intentions, concerns and information needs about COVID-19 vaccination in New Jersey: a qualitative analysis. Vaccines. 2023;11(6):1096. doi:10.3390/vaccines11061096.
   Web of Science ®Google Scholar
• Crabtree BF, Miller WL. Doing qualitative research. 3rd ed. Thousand Oaks, California: SAGE Publications, Inc; 2022.
   Google Scholar
• Miller WL, Crabtree BF. Qualitative analysis: how to begin making sense. Fam Pract Res J. 1994 Sep;14(3):289–97.
   PubMedGoogle Scholar
• Hamilton AB, Finley EP. Qualitative methods in implementation research: an introduction. Psychiatry Res. 2019 Oct;280:112516. doi:10.1016/j.psychres.2019.112516.
   PubMed Web of Science ®Google Scholar
• Elwy AR, Wasan AD, Gillman AG, Johnston KL, Dodds N, McFarland C, Greco CM. Using formative evaluation methods to improve clinical implementation efforts: description and an example. Psychiatry Res. 2020 Jan;283:112532. doi:10.1016/j.psychres.2019.112532.
   PubMed Web of Science ®Google Scholar
• Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007 Dec;19(6):349–57. doi:10.1093/intqhc/mzm042.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT. Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1673–9. doi:10.1158/1055-9965.Epi-15-0326.
   PubMed Web of Science ®Google Scholar
• Fenton AT, Eun TJ, Clark JA, Perkins RB. Indicated or elective? The association of providers’ words with HPV vaccine receipt. Hum Vaccin Immunother. 2018;14(10):2503–9. doi:10.1080/21645515.2018.1480237.
   PubMed Web of Science ®Google Scholar
• Kong WY, Huang Q, Thompson P, Grabert BK, Brewer NT, Gilkey MB. Recommending human papillomavirus vaccination at age 9: a national survey of primary care professionals. Acad Pediatr. 2022 May-Jun;22(4):573–80. doi:10.1016/j.acap.2022.01.008.
   PubMed Web of Science ®Google Scholar
• Kahn BZ, Reiter PL, Kritikos KI, Gilkey MB, Queen TL, Brewer NT. Framing of national HPV vaccine recommendations and willingness to recommend at ages 9-10. Hum Vaccin Immunother. 2023 Dec 31;19(1):2172276. doi:10.1080/21645515.2023.2172276.
   PubMed Web of Science ®Google Scholar
• Lake P, Fuzzell L, Brownstein NC, Fontenot HB, Michel A, McIntyre M, Whitmer A, Rossi SL, Perkins RB, Vadaparampil ST. HPV vaccine recommendations by age: a survey of providers in federally qualified health centers. Hum Vaccin Immunother. 2023 Dec 31;19(1):2181610. doi:10.1080/21645515.2023.2181610.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Grabert BK, Malo TL, Hall ME, Brewer NT. Physicians’ rhetorical strategies for motivating HPV vaccination. Soc Sci Med (1982). 2020 Dec;266:113441. doi:10.1016/j.socscimed.2020.113441.
   PubMed Web of Science ®Google Scholar
• O’Leary SC, Frost HM. Does HPV vaccination initiation at age 9, improve HPV initiation and vaccine series completion rates by age 13? Hum Vaccin Immunother. 2023 Dec 31;19(1):2180971. doi:10.1080/21645515.2023.2180971.
   PubMed Web of Science ®Google Scholar
• Szilagyi PG, Albertin CS, Gurfinkel D, Saville AW, Vangala S, Rice JD, Helmkamp L, Zimet GD, Valderrama R, Breck A, et al. Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the US. Vaccine. 2020 Aug 27;38(38):6027–37. doi:10.1016/j.vaccine.2020.06.074.
   PubMed Web of Science ®Google Scholar
• Pingali C, Yankey D, Elam-Evans LD, Markowitz LE, Valier MR, Fredua B, Crowe SJ, Stokley S, Singleton JA. National vaccination coverage among adolescents aged 13-17 years - national immunization survey-Teen, United States, 2021. MMWR Morb Mortal Wkly Rep. 2022 Sep 2;71(35):1101–8. doi:10.15585/mmwr.mm7135a1.
   PubMed Web of Science ®Google Scholar
• Roncancio AM, Vernon SW, Carmack CC, Ward KK, Muñoz BT, Cribbs FL. Hispanic mothers’ beliefs about having their adolescent sons initiate the HPV vaccine series. J Immigr Minor Health. 2019 Dec;21(6):1356–64. doi:10.1007/s10903-018-0847-x.
   PubMed Web of Science ®Google Scholar
• Roncancio AM, Ward KK, Carmack CC, Muñoz BT, Cribbs FL. Hispanic mothers’ beliefs regarding HPV vaccine series completion in their adolescent daughters. Health Educ Res. 2017;32(1):96–106. doi:10.1093/her/cyw055.
   PubMed Web of Science ®Google Scholar
• Brandt HM, Footman A, Adsul P, Ramanadhan S, Kepka D. Implementing interventions to start HPV vaccination at age 9: using the evidence we have. Hum Vaccin Immunother. 2023 Dec 31;19(1):2180250. doi:10.1080/21645515.2023.2180250.
   PubMed Web of Science ®Google Scholar
• Shah PD, Calo WA, Gilkey MB, Boynton MH, Alton Dailey S, Todd KG, Robichaud MO, Margolis MA, Brewer NT. Questions and concerns about HPV vaccine: a communication experiment. Pediatrics. 2019 Feb;143(2). doi:10.1542/peds.2018-1872
   Web of Science ®Google Scholar
• Hirth JM, Fuchs EL, Chang M, Fernandez ME, Berenson AB. Variations in reason for intention not to vaccinate across time, region, and by race/ethnicity, NIS-Teen (2008-2016). Vaccine. 2019 Jan 21;37(4):595–601. doi:10.1016/j.vaccine.2018.12.017.
   PubMed Web of Science ®Google Scholar
• Beavis A, Krakow M, Levinson K, Rositch AF. Reasons for lack of HPV vaccine initiation in NIS-Teen over time: shifting the focus from gender and sexuality to necessity and safety. J Adolesc Health. 2018 Nov;63(5):652–6. doi:10.1016/j.jadohealth.2018.06.024.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Mohan D, Janssen EM, McRee AL, Kornides ML, Bridges JFP. Exploring variation in parental worries about HPV vaccination: a latent-class analysis. Hum Vaccin Immunother. 2019;15(7–8):1745–51. doi:10.1080/21645515.2019.1574157.
   PubMed Web of Science ®Google Scholar
• Adjei Boakye E, Nair M, Abouelella DK, Joseph CLM, Gerend MA, Subramaniam DS, Osazuwa-Peters N. Trends in reasons for human papillomavirus vaccine hesitancy: 2010-2020. Pediatrics. 2023 May 23;151(6). doi:10.1542/peds.2022-060410.
   PubMed Web of Science ®Google Scholar
• Sonawane K, Lin Y-Y, Damgacioglu H, Zhu Y, Fernandez ME, Montealegre JR, Cazaban CG, Li R, Lairson DR, Lin Y, et al. Trends in human papillomavirus vaccine safety concerns and adverse event reporting in the United States. JAMA Netw Open. 2021;4(9):e2124502–e2124502. doi:10.1001/jamanetworkopen.2021.24502.
   PubMed Web of Science ®Google Scholar
• Shah PD, Calo WA, Gilkey MB, Margolis MA, Dailey SA, Todd KG, Brewer NT. Easing human papillomavirus vaccine hesitancy: a communication experiment with U.S. Parents. Am J Prev Med. 2021 Jul;61(1):88–95. doi:10.1016/j.amepre.2021.02.009.
   PubMed Web of Science ®Google Scholar
• CARE COH, PATIENT- IF, CARE F-C. Patient- and family-centered care and the pediatrician’s role. Pediatrics. 2012;129(2):394–404. doi:10.1542/peds.2011-3084.
   PubMed Web of Science ®Google Scholar
• Navin MC, Wasserman JA. Capacity for preferences and pediatric assent: implications for pediatric practice. Hastings Cent Rep. 2019;49(1):43–51. doi:10.1002/hast.980.
   PubMed Web of Science ®Google Scholar
• Zimet GD, Silverman RD, Bednarczyk RA, English A. Adolescent consent for human papillomavirus vaccine: ethical, legal, and practical considerations. J Pediatr. 2021 Apr;231:24–30. doi:10.1016/j.jpeds.2021.01.026.
   PubMed Web of Science ®Google Scholar
• Fenton A, Eun TJ, Clark JA, Perkins RB. Calling the shots? adolescents’ influence on human papillomavirus vaccine decision-making during clinical encounters. J Adolesc Health. 2020 Apr;66(4):447–54. doi:10.1016/j.jadohealth.2019.10.020.
   PubMed Web of Science ®Google Scholar
• Morales-Campos DY, Zimet GD, Kahn JA. Human papillomavirus vaccine hesitancy in the United States. Pediatr Clin North Am. 2023 Apr;70(2):211–26. doi:10.1016/j.pcl.2022.11.002.
   PubMed Web of Science ®Google Scholar
• Foley S, Nkonga J, Fisher-Borne M. Engaging health plans to prioritize HPV vaccination and initiate at age 9. Hum Vaccin Immunother. 2023 Dec 31;19(1):2167906. doi:10.1080/21645515.2023.2167906.
   PubMed Web of Science ®Google Scholar
• Cates JR, Diehl SJ, Fuemmeler BF, North SW, Chung RJ, Hill JF, Coyne-Beasley T. Toward optimal communication about HPV vaccination for preteens and their parents: evaluation of an online training for pediatric and family medicine health care providers. J Public Health Manag Pract. 2020 Mar/Apr;26(2):159–67. doi:10.1097/phh.0000000000001022.
   PubMed Web of Science ®Google Scholar
• Dempsey AF, Pyrznawoski J, Lockhart S, Barnard J, Campagna EJ, Garrett K, Fisher A, Dickinson LM, O’Leary ST. Effect of a health care professional communication training intervention on adolescent human papillomavirus vaccination: a cluster randomized clinical trial. JAMA Pediatr. 2018 May 7;172(5):e180016. doi:10.1001/jamapediatrics.2018.0016.
   PubMed Web of Science ®Google Scholar
• Grabert BK, Kurtzman R, Heisler-MacKinnon J, Leeman J, Bjork A, Kameny M, Liu A, Todd K, Alton Dailey S, Smith K, et al. Implementation of quality improvement coaching versus physician communication training for improving human papillomavirus vaccination in primary care: a randomized implementation trial. Transl Behav Med. 2021 Jul 9;12(1). doi:10.1093/tbm/ibab071.
   Web of Science ®Google Scholar
• Guest G, Bunce A, Johnson L. How many interviews are enough?: an experiment with data saturation and variability. Field Method. 2006 Feb 1;18(1):59–82. doi:10.1177/1525822X05279903.
   Web of Science ®Google Scholar
• Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: a systematic review of empirical tests. Social Sci Med. 2022 Jan 1;292:114523. doi:10.1016/j.socscimed.2021.114523.
   PubMed Web of Science ®Google Scholar
• Labor USDo. General facts on women and job based health; Updated 2018 [accessed 2023 Sept 1]. https://www.dol.gov/sites/dolgov/files/ebsa/about-ebsa/our-activities/resource-center/fact-sheets/women-and-job-based-health.pdf.
   Google Scholar
• Footman A, Kanney N, Niccolai LM, Zimet GD, Overton ET, Davies SL, Van Der Pol B. Parents’ acceptance of COVID-19 compared to human papillomavirus vaccines. J Adolesc Health. 2022 Dec;71(6):673–8. doi:10.1016/j.jadohealth.2022.07.015.
   PubMed Web of Science ®Google Scholar
• Panozzo CA, Head KJ, Kornides ML, Feemster KA, Zimet GD. Tailored messages addressing human papillomavirus vaccination concerns improves behavioral intent among mothers: a randomized controlled trial. J Adolesc Health. 2020 Aug;67(2):253–61. doi:10.1016/j.jadohealth.2020.01.024.
   PubMed Web of Science ®Google Scholar